Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Velchec, V."'
Autor:
Zabel, M., Schlögl, S., Lubinski, A., Svendsen, J. H., Bauer, A., Arbelo, E., Brusich, S., Conen, D., Cygankiewicz, I., Dommasch, M., Flevari, P., Galuszka, J., Hansen, J., Hasenfuß, G., Hatala, R., Huikuri, H. V., Kenttä, T., Kuczejko, T., Haarmann, H., Harden, M., Iovev, S., Kääb, S., Kaliska, G., Katsimardos, A., Kasprzak, J. D., Qavoq, D., Lüthje, L., Malik, M., Novotny, T., Pavlovic, N., Perge, P., Röver, C., Schmidt, G., Shalganov, T., Sritharan, R., Svetlosak, M., Sallo, Z., Szavits-Nossan, J., Traykov, V., Vandenberk, B., Velchec, V., Vos, M. A., Willich, S. N., Friede, T., Willems, R., Merkely, B., Sticherling, C., investigators, the EU-CERT-ICD study
Publikováno v:
Journal of Electrocardiology, 2019
BACKGROUND. The clinical effectiveness of primary prevention implantable cardioverter defibrillator (ICD) therapy is under debate. It is urgently needed to better identify patients who benefit from prophylactic ICD therapy. The EUropean Comparative E
Externí odkaz:
http://arxiv.org/abs/1909.05571